MC Plus Material – 15_Overview of the FY2026 Medical Fee Revision 15. Appropriate Evaluation of Medical Technologies Page 49 – Center for Policy Studies

News Highlights

The material from the Center for Policy Studies (MC Plus Material – 15) regarding the overview of the FY2026 medical fee revision focuses on the appropriate evaluation of medical technologies. This suggests the importance of mid-to-long-term management and business succession strategies in view of this revision cycle. It also points to management and tax issues arising from M&A and group formation, such as maintaining facility standards through economies of scale, dispersing the burden of capital investment, and utilizing tax incentives by transitioning to specific medical corporations or social medical corporations.

M&A Medical Editorial Department’s Perspective

The overview of the FY2026 medical fee revision, particularly the item “Appropriate Evaluation of Medical Technologies,” is crucial as it directly impacts the revenue structure of individual medical institutions. This revision cycle is not merely a change in regulations but can serve as a compass for mid-to-long-term management strategies and, consequently, business succession strategies. For instance, newly established medical technologies or revisions to the evaluation of existing technologies will significantly affect the profitability of medical institutions with strengths in specific departments or specialized fields. From the perspective of M&A Medical (CentralMedience Inc.), capturing these revision trends and constructing schemes that maximize tax benefits through participation in groups that can enjoy economies of scale or by changing corporate status are effective options for enhancing sustainability for medical institutions struggling with a lack of successors or declining financial strength. The impact of the revision may become more severe, especially for small and medium-sized medical institutions responsible for regional healthcare.

Points Highlighted by This News

• The “Appropriate Evaluation of Medical Technologies” in the FY2026 revision should be closely monitored as a factor influencing changes in the revenue structure.
• The medical fee revision cycle serves as an important opportunity for medical institutions to formulate mid-to-long-term management and business succession plans.
• Economies of scale (maintaining facility standards, dispersing capital investment burden) can be a direct motivation for group formation and M&A.
• Transitioning to a specific medical corporation or social medical corporation should be linked with M&A strategies from the perspective of optimizing tax schemes.

Practical Questions Arising from This News

• How might the evaluation of technology fees for our institution’s core medical departments change with this revision?
• If we form a group, how specifically can facility standards be maintained and joint capital investments be advanced?
• What are the differences in tax advantages and disadvantages between transitioning to a specific medical corporation or social medical corporation and M&A under the current corporate structure?

If You Feel “Should I Consult Too?”

The trends concerning the overview of the FY2026 medical fee revision, especially the “Appropriate Evaluation of Medical Technologies,” may directly impact your institution’s future profitability. If you wish to minimize the impact of the revision and instead seize it as an opportunity for growth, this is a good time to comprehensively review your mid-to-long-term management strategy and business succession strategy. In particular, if you are considering utilizing economies of scale or tax schemes, early consultation with experts is essential for charting a concrete path toward your institution’s sustainable development.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics on a complete success fee basis. Consultations are accepted with strict confidentiality. Free consultations are available here.